Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Carvedilol Prospective Randomized Cumulative Survival

Trial Profile

Carvedilol Prospective Randomized Cumulative Survival

Phase of Trial: Phase III

Latest Information Update: 02 Oct 2006

At a glance

  • Drugs Carvedilol (Primary) ; Spironolactone
  • Indications Chronic heart failure; Heart failure
  • Focus Registrational; Therapeutic Use
  • Acronyms COPERNICUS
  • Sponsors GlaxoSmithKline; Roche
  • Most Recent Events

    • 02 Oct 2006 Status change
    • 30 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top